Pertussis: challenges today and for the future.
Pediatric Infectious Diseases, Mattel Children's Hospital, Los Angeles, California, United States of America. jcherry@mednet.ucla.edu
James D
JD
Cherry
D000818:Animals; D001886:Bordetella pertussis / Q000276:immunology* / Q000378:metabolism; D021821:Communicable Diseases, Emerging / Q000453:epidemiology / Q000276:immunology / Q000382:microbiology; D015721:Diphtheria-Tetanus-Pertussis Vaccine / Q000627:therapeutic use; D022681:Diphtheria-Tetanus-acellular Pertussis Vaccines / Q000627:therapeutic use; D019456:Health Transition; D006801:Humans; D037342:Pertussis Toxin / Q000096:biosynthesis; D010567:Pertussis Vaccine / Q000276:immunology / Q000627:therapeutic use*; D017211:Treatment Failure; D014481:United States / Q000453:epidemiology; D014917:Whooping Cough / Q000453:epidemiology / Q000276:immunology / Q000382:microbiology / Q000517:prevention & control*
D015721:Diphtheria-Tetanus-Pertussis Vaccine; D022681:Diphtheria-Tetanus-acellular Pertussis Vaccines; D010567:Pertussis Vaccine; D037342:Pertussis Toxin